Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial
在 ASC4FIRST 试验中,Asciminib 在新诊断的慢性粒细胞白血病患者中展现出优异的疗效和安全性。
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2025029210
Cortes, Jorge E; Hughes, Timothy P; Wang, Jianxiang; Kim, Dong-Wook; Kim, Dennis Dong Hwan; Mayer, Jiri; Goh, Yeow-Tee; le Coutre, Philipp; Etienne, Gabriel; Kim, Inho; Andorsky, David J; Bombaci, Felice; Issa, Ghayas C; Takahashi, Naoto; Kapoor, Shruti; Jinwal, Rajendra; Malek, Kamel; McCulloch, Tracey; Yau, Lillian; Larson, Richard A; Hochhaus, Andreas